PTPN2, A Key Predictor of Prognosis for Pancreatic Adenocarcinoma, Significantly Regulates Cell Cycles, Apoptosis, and Metastasis

Abstract

These findings provide a comprehensive analysis of the PTPN family members, and for PAAD, they also demonstrate that <i>PTPN2</i> is a diagnostic biomarker and a therapeutic target.